Page last updated: 2024-08-26

paxilline and Carcinoma, Mucoepidermoid

paxilline has been researched along with Carcinoma, Mucoepidermoid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, CH; Cho, SD; Han, JM; Hong, KO; Hong, SD; Shin, JA; Yang, IH	1

Other Studies

1 other study(ies) available for paxilline and Carcinoma, Mucoepidermoid

Article	Year
Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization. Molecules (Basel, Switzerland), 2019, May-19, Volume: 24, Issue:10 Topics: Actins; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Focal Adhesion Protein-Tyrosine Kinases; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Paxillin; Signal Transduction	2019

Article

Year

Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization.

Molecules (Basel, Switzerland), 2019, May-19, Volume: 24, Issue:10

Topics: Actins; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Focal Adhesion Protein-Tyrosine Kinases; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Paxillin; Signal Transduction

2019